Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens.

By David Kim, J. Quinn, B. Pinsky, Nigam H. Shah, Ian Brown. Journal of the American Medical Association (JAMA), 2020

732 citations recorded by the source corpus.

This study describes the prevalence of SARS-CoV-2 co-infection with noncoronavirus respiratory pathogens in a sample of symptomatic patients undergoing PCR testing in March 2020.

Subfields: Epidemiology, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/7ed3882671ae92f707ff6c8f77e63f5bf669f747

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

T. Rawson
N. Zhu
Luke S.P. Moore
Nisha Ranganathan
K. Skolimowska
M. Gilchrist
G. Satta
G. Cooke

Citations in the corpus

Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing (2020, background): “Kim and colleagues [34] report 116 individual patients undergoing respiratory pathogen sampling for atypical organisms, including Chlamydia pneumoniae and Mycoplasma pneumoniae.”
Misinformation Dissemination in Twitter in the COVID-19 Era (2020, unknown): “Additionally, a recent study does suggest higher rates of coinfection between SARS-CoV-2 and other respiratory pathogens.(8) Secondly, we found that some individuals believe that having received the influenza vaccine can lead to a positive COVID test.”
Co-infections in people with COVID-19: a systematic review and meta-analysis (2020, unknown): “20-22, 25, (35)Two studies reported data on deceased COVID-19 patients 41 and one study included nonhospitalised patients.(42) Most data were for adults (range of median ages 42 to 63 years), with only three small studies reporting data exclusively from children (n=86).”